These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15758432)

  • 1. How drugs decrease fracture risk: lessons from trials.
    Cummings SR
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):198-200. PubMed ID: 15758432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA.
    Blake GM; Griffith JF; Yeung DK; Leung PC; Fogelman I
    Bone; 2009 Mar; 44(3):495-501. PubMed ID: 19059505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism and the skeleton.
    Mosekilde L
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
    Kaptoge S; Benevolenskaya LI; Bhalla AK; Cannata JB; Boonen S; Falch JA; Felsenberg D; Finn JD; Nuti R; Hoszowski K; Lorenc R; Miazgowski T; Jajic I; Lyritis G; Masaryk P; Naves-Diaz M; Poor G; Reid DM; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Roy DK; Lunt M; Pye SR; O'neill TW; Silman AJ; Reeve J
    Bone; 2005 Mar; 36(3):387-98. PubMed ID: 15777673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucocorticoids and osteoporosis].
    Zikán V
    Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is cortical bone hip? What determines cortical bone properties?
    Epstein S
    Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
    Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
    Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.
    Szulc P; Munoz F; Duboeuf F; Marchand F; Delmas PD
    Bone; 2006 Apr; 38(4):595-602. PubMed ID: 16249130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of the effect of endogenous estrogen on spine fracture risk and bone structure in elderly women and an assessment of its diagnostic usefulness.
    Prince RL; Dick IM; Beilby J; Dhaliwal SS; Devine A
    Bone; 2007 Jul; 41(1):33-8. PubMed ID: 17482901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
    Bonnick SL; Shulman L
    Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging concepts in osteoporosis and bone strength.
    Rubin CD
    Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
    Seeman E
    Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis.
    Jamal SA; Hayden JA; Beyene J
    Am J Kidney Dis; 2007 May; 49(5):674-81. PubMed ID: 17472850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
    Leslie WD; Tsang JF; Lix LM
    Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifracture efficacy of antiresorptive agents are related to changes in bone density.
    Wasnich RD; Miller PD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):231-6. PubMed ID: 10634392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fracture of the spine; treated by early mobilization & exercise].
    HANSEN EC; VILLUMSEN AL
    Nord Med; 1959 Jun; 61(23):847-9. PubMed ID: 13667047
    [No Abstract]   [Full Text] [Related]  

  • 20. Fracture of the anterior inferior spine of the ilium.
    STANISAVLJEVIC S
    Arch Ortop; 1958; 71(5):626-30. PubMed ID: 13607141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.